Sub-Saharan
Introduction
Measles virus (MV) is the prototype and the only known human pathogen of the morbilliviruses. Since it is considered to be monotypic and essentially without animal reservoir (Norrby, 1995) , measles control and eradication should be within reach of aggressive vaccination campaigns. To achieve this goal, it is essential that national health efforts concentrate on strategies to interrupt virus circulation. Molecular epidemiology of field isolates has proven to be a powerful tool to monitor circulation of infectious virus (Rota et al., b, 1996 Rima et al., 1995 ; Kreis et al., 1997) . In the Americas, the molecular analysis of virus isolates has demonstrated that virus circulation has been effectively disrupted and has ceased in large parts of the continent (Rota et al., 1996 ; . However, in most other continents, the virus is still endemic (WHO, 1997) and virus transmission continues within geographically more or less confined areas without the need for reintroduced exogenous virus. In some regions, specific virus genotypes have established themselves. A comprehensive study of isolates from different geographic regions will permit the discrimination between imported and endogenous cases. In countries where measles seems to be under control, the geographic origin of reintroduced virus can potentially be determined. Genotype variability and distribution can help to assess the impact of vaccination efforts in endemic areas.
No field isolates from the vast region of West Africa, including Nigeria, the most populous African nation, have ever been studied. Except for some rare isolates from Cameroon and Gabon from the mid-1980s and Gambian isolates in the 1990s, 0001-5947 # 1999 SGM no MV field strains have ever been investigated in northern and central Africa (Taylor et al., 1991 ; Rota et al., 1994 b ; Outlaw et al., 1997 ). Yet, this may well be the global region with the highest measles morbidity and mortality (Dollimore et al., 1997 ; WHO, 1996) . In Nigeria, for instance, measles is endemic and the death toll is exceedingly high in young infants (Byass et al., 1995 ; O. Ikusika & F. Adu, unpublished data (Taylor et al., 1991 ; Rima et al., 1995) , the isolates were tentatively assigned to a new genotype of clade B. Sequence comparison with earlier isolates contributes to a better understanding of measles epidemiology in sub-Saharan Africa.
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Methods
Patients. Most viruses were isolated in February and March 1998 from blood or throat-swabs of patients (7-108 months of age) with clinical measles. Three additional isolates were obtained in April and November 1997 (Table 1) . Samples were taken within 6 days after onset of the rash. Four samples (Ibadan.NIE\7.98\2, Ibadan.NIE\9.98\8, Ibadan.NIE\10.98\6, Accra.GHA\9.98\1) were drawn from children of 6-9 months of age, i.e. before the recommended age of vaccination of 9 months. Sixteen children were vaccinated according to their parents' memory and 21, including the above four children below 9 months of age, were reportedly not vaccinated. The vaccination status of 10 patients was unknown. The Ibadan samples were collected mainly from the paediatric outpatient departments of three public hospitals [Adeoyo State Hospital (n l 15), Oni Memorial Children Hospital (n l 13), University College Hospital (n l 4)] and one private hospital (St Mary's Hospital ; n l 3). Samples from Lagos were collected in the Massey Children's Hospital (n l 2), the Lagos University Teaching Hospital (n l 2) and the Infectious Disease Hospital (n l 1). All samples from Ghana were from the Princess Mary Children's Hospital, Accra (n l 4). Peripheral blood lymphocytes or the cellular fraction of throat-swabs were co-cultivated with a semi-confluent monolayer of B95a cells (an Epstein-Barr virus-transformed marmoset B cell line of lymphoblastoid origin ; Kobune et al., 1990) . Cytopathic effect appeared after 1-14 days. The complete culture was harvested, aliquoted and stored in liquid nitrogen or at k20 mC.
Sequencing. Total RNA was extracted using a modified guanidinium-acid phenol method (Chomczynski & Sacchi, 1987) . In brief, infected cells were incubated with Trizol (GIBCO Life Technologies) and RNA was extracted with chloroform and precipitated in isopropanol. Specific cDNA of MV NP mRNA was synthesized by reverse transcription using Superscript Reverse Transcriptase (GIBCO Life Technologies) and primer NP4rev (ACAATGATGGAGGGTAGGCG-GATGTT). The cDNA was further amplified using the primers NP1seq (TTCAAGATCCTATTATCAGGGACAAGAG) and NP4rev to obtain a 1676 bp fragment, and by semi-nested PCR with NP1seq\NP2rev (TGTAGGGTGCAGTTTCCCCCATTT) and NP3seq (TTGCTGGTG-AGTTATCCACACTTG)\NP4rev, respectively, to increase the specificity. The resulting two fragments, each corresponding to about one-half of the gene (985 and 763 bp long) were purified in a 1 % agarose gel. RT-PCR products were directly sequenced with the Dye Terminator Cycle Sequencing kit (Perkin-Elmer) and four specific primers for each strand were used in addition to the above primers, NP1rev (GGGCT-AGGATGGTACCCAGAATC), NP2seq (TTTCACATGATGATCCA-ATTAGTAGTG), NP3rev (GACTCCGATGCAGTGTCAATGTCT) and NP4seq (GAGAAACCGGGCCCAGCAGA). Sequencing was performed on an ABI 377 Automatic DNA Sequencer (Perkin-Elmer). Sequence data were analysed using the CLUSTAL X program (Thompson et al., 1994) for multiple alignments and a version of the PHYLIP package (Felsenstein, 1993) running on the HUSAR computer at the DKFZ (Heidelberg, Germany) for phylogenetic analysis. Dendrograms were drawn using the neighbour-joining method and confirmed with 1000 bootstrap replicates. Similar results were obtained with the maximum likelihood method and 100 bootstrap replicates (data not shown). All virus isolates, genotypes and clades were designated according to the new official WHO nomenclature (WHO, 1998) . Sequences used for comparison in Fig. 3 were described by Taylor et al. (1991) Rota et al. (1996) (Gambia 91, Palau 94, NJ 94 and ENG 93), Kreis et al. (1997) (Jhb 1\86, Jhb 1\88 and Jhb 3\94) and Xu et al. (1998) (China 1\93 and China 7\93) .
Results
Sequence variability among the isolates
Since the virus isolates described here are the first from this major region of West Africa (Nigeria and Ghana) the complete protein-encoding region of the NP gene was sequenced. The nucleotide divergence in the NP gene among our isolates varied from 0n0 to 2n6 % but only about one-third translated into mutated amino acids.
Comparison with a consensus sequence
The sequences of four isolates from Accra (Ghana), five from Lagos and 36 from Ibadan (both Nigeria) were compared to a consensus sequence based on 34 selected MV NP sequences of the EMBL database covering all genetic subgroups defined by the WHO (1998). The 456 nucleotides at the 3h terminus were identical with the consensus sequence described by Rima et al. (1995) and by Taylor et al. (1991) . The number of mutations in our isolates was in the range 35-44 at the nucleotide level and 4-7 at the amino acid level. Particularly in the C-terminal domain (nt 1230-1285), up to 3n7 % of the nucleotides displayed mutations, leading to a maximum of seven amino acid substitutions. Within the N-terminal domain (nt 108-1229), a maximum of 2n5 % of the nucleotide positions showed mutations, but almost all of these were silent at the amino acid level. Within this domain, other variable regions with a density of nucleotide mutations similar to the Cterminal variable region seem to be embedded. In contrast to the C-terminal mutations, these are mostly silent (data not shown).
To identify the clade and the genotype to which our viruses are most closely related, several types of comparisons were made. (i) Fig. 1 (a) shows that the divergence of four representative Nigerian\Ghanaian isolates is lowest in comparison to the reference sequences of the genotypes of clades A and B. (ii) Fig. 1 (b) describes the number of shared mutations between the reference sequences and the above representative isolates with respect to the consensus sequence. The number of mutations shared with clade B viruses is 2-9 times higher than with reference viruses of other clades. (iii) In Fig. 2 , the same representative sequences are aligned with the clade-specific consensus sequences and the archetypes for the B1 and B2 genotypes. The specific mutations of clade B are found in our isolates. Mutation patterns are similar but not identical to the B1 and B2 viruses. (iv) Finally, a dendrogram shows some representative isolates of reference sequences (Fig. 3) . Bootstrap values were significant for all clades but not for all genotypes as has been discussed previously (Rima et al., 1997) . The above comparisons demonstrate that our isolates are most closely related to clade B.
Comparison with clade B isolates
All isolates in Table 1 share the following nucleotide substitutions : 383C T, 470C T, 473C T, 494A G, 542A G, 548C T, 623C T, 668G A, 701G
A, 719G A, 767G A, 1163T C, 1214G A, 1334G
A, 1394A G, 1418T C, 1449A G, 1549C T, 1583T C, 1595C T and 1673T C (nucleotide numbering according to Mori et al., 1993) . Thirteen of these mutations (in bold) are not found in the B2 subgroup (isolates R103, R113 and R118 ; Rota et al., 1994 b ; Taylor et al., 1991) ; four mutations (underlined) are not found in the B1 subgroup (Y22 and Y14 ; Rota et al., 1994 b ; Taylor et al., 1991) . The sequences form two disparate clusters. Cluster 1 (n l 27) contains the 1997 isolates from Ibadan and 21 1998 isolates from Ibadan and three viruses from Lagos. Cluster 2 (n l 17) comprises all isolates from Ghana, two viruses from Lagos and 11 viruses from Ibadan (all 1998). Within cluster 1, sequence divergence was maximally 0n8% (2n0 % in the C terminus) and all sequences shared additional changes at positions 428T C, 461A G, 593A C, 659C T, 698A C, 983G A, 1079C T, 1184A G, 1436T C, 1458T C and 1586C T. In cluster 2, sequences varied by up to 1n7% (3n1 % in the C terminus) with the common mutations 269G A, 410G A, 518T C, 533C T, 1127A G, 1364T C, 1434A G and 1688G A. Only Lagos.NIE\10.98 lacked the changes at positions 269, 410, 1127, 1434 and 1688. All of the above-mentioned characteristic mutations were silent, except for the changes at 1434 leading to 443S G, 1449 leading to 448R G, 1458 leading to 451Y H and 1549 leading to 481S F (all located in the variable 456 nt of the C terminus).
A difference of 1n7-2n7 % was found (1n8-4n6 % in the C terminus) between the two clusters. The following differences were found with respect to earlier African isolates (Cameroon 1983 and Gabon 1984, B1 and B2, respectively, according to WHO nomenclature) : between cluster 1 and B1, 2n4% (3n3% in the C terminus) ; cluster 2 and B1, 2n4% (2n6 % in the C terminus) ; cluster 1 and B2, 3n2% (4n1 % in the C terminus) ; cluster 2 and B2, 3n3% (4n4 % in the C terminus) -an indication of a certain distance between the old and the recent isolates.
Discussion
Most of the isolates described in this study were collected in four hospitals within a two month period during a single outbreak in the city of Ibadan. Despite this narrow time-span and the limited out-reach, these isolates form a relatively heterogeneous group with up to 4n6 % sequence divergence in the C-terminal variable domain of the NP. They represent two independent clusters with 11 and 8 specific mutations in clusters 1 and 2, respectively. Viruses of the two clusters were not confined to individual hospitals and were obtained throughout the outbreak. Local epidemics are mostly sustained by genetically homogeneous viruses. However, a similar heterogeneity was also observed by Xu et al. (1998) during an outbreak in China. During a long-term study of cases in Europe, a clade switch was observed (Rima et al., 1997) and, in the US, the upcoming of different genotypes was explained by genetically diverse, imported cases (Rota et al., 1996) . Viruses of the two clusters also co-circulated in Lagos. Moreover, cluster 2 viruses were found at the same time in Accra, some 500 km away from Ibadan and cluster 1 viruses were already circulating in Ibadan in 1997. These observations suggest that the viruses were not introduced by a particular reference case but rather that they circulate endemically over a vast region where the number of susceptible individuals not only seems to be high enough to support the extensive circulation of a single virus but at least two distinct viruses. The endemic cocirculation of several viruses may well be characteristic for communities with low vaccination rates, if only sufficient numbers of viruses are sampled.
The new WHO nomenclature differentiates between eight distinct clades (named A-H), some of which may be extinct. Clades B, C and D comprise several genotypes. The dendrogram with our new isolates shows no major reshuffling in comparison to earlier versions, so the relationship between the groups should now be stable. Some more recent African isolates from South Africa (Kreis et al., 1997) and one from Kenya belong to clades that were mainly associated with Europe and the US. Our isolates clearly belong to clade B, which has always been associated with the African continent and which contains most of the earlier African isolates. However, our isolates are quite distinct from the prototypes of the subgroups B1 (isolated in Cameroon in 1983) and B2 (isolated in Gabon in 1984) , in terms of the degree of divergent nucleotides, common mutations (in the 3h variable region of NP) and bootstrap values. Among all known isolates, only NY 94 (Rota et al., 1996) shares all mutations common among the isolates of Table 1 with the exception of 767G A. This 1994 isolate from New York corresponds to our cluster 2 with only 1 % nucleotide sequence difference with its closest relatives (Ibadan.NIE\8.98\4, Ibadan.NIE\8.98\9, Ibadan.NIE\8.98\10, Ibadan.NIE\9.98\1). Interestingly, this virus was epidemiologically linked to an imported case from Kenya. This suggests that this highly stable virus may also circulate between Kenya and Nigeria, throughout sub-Saharan Africa. This is in line with our observation that cluster 2 viruses were also isolated in Ghana.
Although all our isolates clearly belong to clade B, it is difficult to assign them to one of the existing genotypes. The 45 isolates described here are bound to cause considerable reshuffling within the B clade from which, so far, the NP sequences of only seven viruses have been described. On the basis of the dendrogram and the mutations shared by our isolates but not shared by the clade B archetype sequences, we have provisionally assigned a new clade B genotype to our isolates from Nigeria and Ghana (tentatively B3), despite a low bootstrap value (43 %). Although clade-specific bootstrap values are significant ( 80 %), some well-established genotypes, such as D1, D2 and D5 also have low bootstrap values (50-67 %). The reference virus of this genotype would be NY 94 since it was isolated first.
Due to its dissimilarity with both the B1 archetype and our viruses, the Gambia 91 isolate cannot be assigned to a genotype as long as no other comparable isolates are found. As shown below, the designation of a new genotype based on a single isolate is difficult since no shared mutations can be taken into account.
So far no criteria have been established to define the level of differences between clades and genotypes. The usefulness of a definition based on percentage difference, as proposed by Kreis et al. (1997) is limited, since it does not necessarily reflect a common evolution of viruses. A definition based on common characteristic mutations could be more useful but requires a larger number of virus isolates. It is proposed that a new clade is assigned to isolates which do not share most (65-80 %) of the mutations found in a clade-specific consensus sequence as shown in Fig. 2 . For clades with only limited numbers of known isolates (such as clades E and F, which seem to be extinct ; WHO, 1998) , the number of characteristic mutations may be artificially high. Within a clade, genotypes would be defined by the number of shared mutations that are only found in a given set of isolates. Two sets of viruses would belong to different genotypes when each group contains a minimal number of set-specific mutations. For instance, new isolates would be assigned to distinct genotypes if the sum of setspecific mutations of both sets adds up to at least five (on the C terminus). Within clade D, genotype 1 and 2 diverge by six characteristic mutations, D3 and D5 by 13 mutations, D3 and D1 by 15 mutations. According to the new clade B structure proposed above, the sums of the genotype-specific mutations are as follows : B1\B3, five mutations ; B1\B2, 14 mutations ; B2\B3, 13 mutations. It is important to note that the significance of these numbers increases considerably with the size of the compared sets of isolates, highlighting the need for collecting larger numbers of virus isolates.
The virus isolates described here are the cause of the staggering mortality rates among Nigerian infants and children. Although information concerning the vaccination status of the measles patients may not be very reliable in the absence of documented proof, it is likely that a considerable number of cases were due to primary and\or secondary vaccine failure. Vaccine handling as well as the poor nutritional and health status of children could explain low seroconversion rates. This is the first phylogenetic study based on NP of a large number of MV isolates conducted in Africa with the exception of South Africa. Results of this study suggest that clade B viruses are prevalent in sub-Saharan Africa while non-B viruses seem to dominate the south of Africa (Kreis et al., 1998) . Considering the size of the continent and the reservoir of susceptible individuals, it seems likely that other genotypes will emerge and that the diversity of known circulating MV will continue to grow.
